Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data
The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.
Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device
Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.
FDA highlights new Class I recall for Dexcom CGM app
Dexcom recalled its G6 smartphone app after a software error was causing it to stop working with no warning. This is a Class I recall, which means failing to follow the company's instructions could result in a serious adverse event.
Telehealth ketamine service sued after patient dies of overdose
Mindbloom, a telemedicine company that provides ketamine for depression and anxiety as part of a treatment program, is accused of negligence in the death of Philip Ward. But the facts leading up to his overdose are in dispute.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).

Rakesh Gopinathannair, MD, FAHA, FACC, FHRS, director of cardiac electrophysiology laboratories at the Kansas City Heart Rhythm Institute, explains lessons from the AHA statement on COVID caused arrhythmias.

Key details associated with the treatment of COVID-induced arrhythmias

Rakesh Gopinathannair, MD, lead author of a recent American Heart Association scientific statement on cardiac arrhythmias associated with COVID-19, reviewed the latest science associated with this important topic.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Experts in interventional cardiology, medical billing unite to discuss Shockwave Medical’s IVL technology

Intravascular lithotripsy has quickly emerged as one of healthcare’s most in-demand technologies. Now Shockwave Medical, part of Johnson & Johnson MedTech, is co-hosting a webinar designed to teach coding and billing specialists how to code appropriately for peripheral and coronary IVL procedures.

A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon

Heart surgeons may deliver better outcomes during stressful procedures

Excessive stress may still be harmful to a surgeon's performance, researchers warned, but moderate stress early on during a procedure appears to reduce the odds of a major complication.

Aortic valve calcium scores help predict need for a permanent pacemaker after TAVR

RBBB remains the single strongest predictor for PPMI after TAVR, but high AV calcium scores still provide care teams with considerable value.

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.

statue justice legal verdict malpractice case lawsuit scale

Congressional candidate physician sues hospital and doctor for death of father

Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

Diabetes reduces survival after SAVR, but not TAVR

"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."

DEA wants to permanently anchor some COVID-era prescription regulations

The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.

Clinical

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device

FDA highlights new Class I recall for Dexcom CGM app

Telehealth ketamine service sued after patient dies of overdose

Pulmonary embolism thrombectomy use increases by more than 700%